KEY PRODUCTS
Experts in producing high-quality APIs from natural sources, specializing in advanced extraction and isolation techniques.
01 1Phytex Australia
01 1METHSCOPOLAMINE BROMIDE
01 1Australia
01 1Active
01 1Complete
Experts in producing high-quality APIs from natural sources, specializing in advanced extraction and isolation techniques.
GDUFA
DMF Review : Complete
Rev. Date : 2022-02-17
Pay. Date : 2021-09-16
DMF Number : 7410
Submission : 1988-03-30
Status : Active
Type : II
20
Phytex Australia Pvt Ltd, based in Australia, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for Experts in producing high-quality APIs from natural sources, specializing in advanced extraction and isolation techniques.
One of their notable products is METHSCOPOLAMINE BROMIDE, with a corresponding US DMF Number 7410.
Remarkably, this DMF maintains an Active status since its submission on March 30, 1988, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 17, 2022, and payment made on September 16, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
